Carta Healthcare

Carta Healthcare

Provides data solutions for healthcare institutions

About Carta Healthcare

Simplify's Rating
Why Carta Healthcare is rated
B+
Rated B on Competitive Edge
Rated B on Growth Potential
Rated A on Rating Differentiation

Industries

Data & Analytics

Consulting

Healthcare

Company Size

51-200

Company Stage

Series B

Total Funding

$41.1M

Headquarters

Palo Alto, California

Founded

2017

Overview

Carta Healthcare provides data solutions specifically designed for the healthcare sector. Their services aim to enhance the patient experience by making healthcare data more accessible and useful for hospitals and medical professionals. The company employs a team of experts to tackle common data-related issues, which allows healthcare providers to prioritize patient care, improve operational efficiency, and support research initiatives. Unlike many competitors, Carta Healthcare focuses on streamlining workflows, enabling nurses and physicians to dedicate more time to their medical practices. The company's goal is to empower healthcare institutions by offering technology and consulting services that improve data management and patient outcomes.

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven solutions reduce clinician workload, improving job satisfaction and efficiency.
  • Carta Healthcare's platform lowers data abstraction costs by over 50%, enhancing hospital operations.
  • Winning multiple innovation awards highlights Carta Healthcare's leadership in healthcare technology.

What critics are saying

  • Integration challenges from acquiring Realyze Intelligence may disrupt operations and delay benefits.
  • Concerns about AI data quality and oversight could hinder Carta Healthcare's solution adoption.
  • Rapid data volume increase risks inefficiencies in data management and analysis.

What makes Carta Healthcare unique

  • Carta Healthcare uses AI to personalize patient care, improving hospital experiences.
  • The company combines AI with human expertise for accurate clinical data abstraction.
  • Carta Healthcare's acquisition of Realyze Intelligence enhances its AI capabilities in oncology research.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$41.1M

Below

Industry Average

Funded Over

2 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Below Average

Industry standards

$35M
$30M
Patreon
$45M
Linktree
$65M
Substack
$100M
ClickUp

Benefits

Medical, dental, and vision

Unlimited vacation

401(k)

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

2%

2 year growth

-5%
Hit Consultant
Feb 12th, 2025
Survey: 83% Of Clinical Data Abstractors Believe Ai Can Reduce Clinician Workload

Survey: 83% of Clinical Data Abstractors Believe AI Can Reduce Clinician Workload. by Fred Pennic 02/12/2025 Leave a Comment. Image by freepikWhat You Should Know: – Carta Healthcare, a provider of clinical data solutions, recently conducted a survey of clinical data abstractors to understand their perspectives on the use of AI in their profession. – The results reveal a mix of optimism and concerns, highlighting the need for a balanced approach that combines AI’s efficiency with human oversight to ensure data quality and accuracy.The Need for Human-in-the-Loop AIThe survey results highlight the importance of a human-in-the-loop approach to AI in healthcare data abstraction. While AI can automate many tasks, human oversight is essential to ensure data accuracy, address complex cases, and maintain quality control. Key findings of the survey include: Efficiency Gains: The vast majority of abstractors (85%) believe that AI can save time, effort, and costs in data abstraction.Reduced Workload: 83% of abstractors agree that AI can reduce clinicians’ administrative workload.Faster Abstraction: 75% believe AI can speed up the abstraction process.Data Quality Concerns: Despite the potential benefits, 69% of abstractors express concerns about the quality of AI-generated data and the lack of human oversight.Mixed Feelings: While many abstractors are optimistic about using AI (54%), a significant portion remains neutral (28%) or negative (15%).Addressing Adoption ChallengesThe survey also revealed that many healthcare organizations have not yet adopted AI tools for data abstraction. Carta Healthcare aims to address these challenges by:Educating providers: Highlighting the benefits of AI-powered data abstraction and addressing concerns about data quality and human oversight.Providing comprehensive solutions: Offering a platform that combines AI with human expertise to ensure accuracy and reliability.Supporting seamless integration: Integrating its solutions with existing EHR systems and workflows to minimize disruption

PR Newswire
Jan 15th, 2025
Pioneering The Future: Carta Healthcare Wins Big Innovation Award For Healthcare

Acknowledged for its clinical data abstraction platform, Carta Healthcare showcases its leadership in shaping the futureSAN FRANCISCO, Jan. 15, 2025 /PRNewswire/ -- Carta Healthcare®, whose mission is to ignite healthcare improvement by unlocking the power of clinical data, is thrilled to announce its recognition as a winner in the prestigious 2025 BIG Innovation Awards, presented by the Business Intelligence Group. Selected from hundreds of global submissions, Carta Healthcare's clinical data abstraction solution was celebrated for its groundbreaking impact on healthcare innovation."Humanity relies on innovation to improve our lives and the planet," said Russ Fordyce, CEO of the Business Intelligence Group. "We're thrilled to spotlight Carta Healthcare as a shining example of innovation making a profound impact."Clinical data abstraction is essential for hospitals to improve patient care, demonstrate quality, and comply with regulations. Unfortunately, manual clinical data abstraction methods historically have been labor-intensive, time-consuming, and expensive while failing to consistently produce the highest-quality data.Carta Healthcare combines the power of AI technology with expert human abstractors to abstract data and insights that act as catalysts for healthcare transformation. Health systems and hospitals using the Carta Healthcare platform can lower their data abstraction costs by more than 50%, reduce per case abstraction time by two-thirds, and achieve an average 98%-99% Inter-Rater Reliability (IRR), a measure of data abstraction consistency and dependability."Innovation is what enables healthcare organizations to solve their biggest challenges and find new ways to provide better care for individuals and patient populations," said Carta Healthcare CEO, Brent Dover

CityBiz
Jan 6th, 2025
Carta Healthcare Wins AI & Automation Leadership Honors in First Annual Pinnacle Awards for Business

Carta Healthcare(R) whose mission is to ignite healthcare improvement by unlocking the power of clinical data, today announced it has won a Diamond Award for AI & Automation Leadership in the Innovation & Technology category of the first annual Pinnacle Awards for Business.

Pittsburgh Post-Gazette
Dec 9th, 2024
UPMC Enterprises startup is acquired by California company

A Bakery Square startup company that matches cancer patients with clinical trials has been acquired by a California outfit. Realyze Intelligence Inc.,...

PR Newswire
Dec 9th, 2024
Carta Healthcare To Power Oncology Research And Clinical Trials With Acquisition Of Realyze Intelligence, A Upmc Enterprises Company

Clinician-trained AI analyzes electronic records to match ideal patients with studies in seconds rather than hours, optimizing research and reducing costs. SAN FRANCISCO, Dec. 9, 2024 /PRNewswire/ -- Carta Healthcare®, which ignites healthcare improvement by unlocking the power of clinical data, expanded the strength and capabilities of its AI-powered platform with the acquisition of Realyze Intelligence. The Realyze Intelligence solution leverages AI to match patients to clinical trials to accelerate research and reduce costs while providing patients with the latest advances in care. Focused on the oncology space, Realyze Intelligence rapidly analyzes structured and unstructured data in electronic health records (EHRs) to identify ideal patients for clinical trials and other research studies. Realyze Intelligence's clinician-trained AI can assemble appropriate cohorts in seconds instead of the typical hours or days the process consumes when performed manually

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Carta Healthcare right now.

Find jobs on Simplify and start your career today

💡
We update Carta Healthcare's jobs every 8 hours, so check again soon! Browse all jobs →